Home  >  Products  >  ANAPC15 (anaphase promoting complex subunit 15 ) Blocking Peptide (the N terminal of ANAPC15)(100ug)
ANAPC15 (anaphase promoting complex subunit 15 ) Blocking Peptide (the N terminal of ANAPC15)(100ug)

ANAPC15 (anaphase promoting complex subunit 15 ) Blocking Peptide (the N terminal of ANAPC15)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-ANAPC15 Antibody (ARP68090_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP68090
Size: 100ug
Weight: 13kDa
Gene: 25906
Format: Lyophilized powder
Target: ANAPC15 is a component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. In the complex, it plays a role in the release of the mitotic checkpoint complex (MCC) from the APC/C: not required for APC/C activity itself, but promotes the turnover of CDC20 and MCC on the APC/C, thereby participating to the responsiveness of the spindle assembly checkpoint. It is also required for degradation of CDC20.
Alternative names: APC15; C11orf51